Benefits of AZ vaccine outweigh risks, says MHRA
The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine
Read More
Author: Selina McKee
Coronavirus infections drop but R number remains at 1
Data suggest infections in England fell by 60% from February, but the decline is levelling
Read More
Novartis UK announces further HRT patch stock issues
Supplies of Estradot TTS-75 are expected to return to normal within eight weeks
Read More
Nationwide launch for pioneering fertility study
The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births
Read More
Artios, Novartis form cancer therapies collaboration
The deal could be worth as much as $1.3 billion to Artios
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
